Posted on 8 June 20268 June 2026 Roche signs $2.3bn blood cancer drug agreement with Nurix Therapeutics Roche has bought partial rights to Nurix Therapeutics’ bexobrutideg in a deal worth up to $2.3bn that will see the big pharma co...
